{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:15:26Z","timestamp":1793121326564,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Neurogenic bladder dysfunction (NBD) is a frequent complication of neurological diseases including Parkinson\u2019s disease, multiple sclerosis, spinal cord injury, and spina bifida. Managing NBD remains challenging, especially for patients who fail to respond to standard therapies. Sacral neuromodulation (SNM), though FDA-approved for non-neurogenic conditions, is increasingly explored off-label in neurogenic populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Recent studies demonstrate that SNM can improve lower urinary tract symptoms, bladder storage, and emptying in select NBD patients. Small case series and retrospective reviews suggest reduced catheterization and medication use. Technological advances, such as closed-loop systems and MRI-compatible devices, are broadening SNM\u2019s clinical potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>SNM is emerging as a valuable, minimally invasive treatment for neurogenic bladder dysfunction. Careful patient selection and understanding of underlying pathophysiology are essential for success. As evidence grows and device innovations continue, SNM could reshape management strategies for patients with neurogenic bladder.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11934-025-01280-6","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T03:17:25Z","timestamp":1750648645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Off-Label but On-Target: Sacral Neuromodulation for Neurogenic Bladder Dysfunction"],"prefix":"10.1007","volume":"26","author":[{"given":"Keianna","family":"Vogel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nissrine","family":"Nakib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"1280_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/tre.934","volume":"14","author":"A Canagasingham","year":"2023","unstructured":"Canagasingham A, Kovacic J, Popa I, Chung A. Sacral nerve neuromodulation: the past, present and future. Trends Urol Men Health. 2023;14:30\u20133. https:\/\/doi.org\/10.1002\/tre.934.","journal-title":"Trends Urol Men Health"},{"key":"1280_CR2","unstructured":"Feloney MP, Stauss K, Leslie SW. Sacral Neuromodulation [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [updated 2024; cited 2025 Apr 13]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK567751\/"},{"issue":"3","key":"1280_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3390\/medicina60030509","volume":"60","author":"M Spilotros","year":"2024","unstructured":"Spilotros M, Gerbasi S, Lasorsa F, de Rienzo G, Balducci L, Ditonno P, et al. Sacral neuromodulation: device improvement and current applications in urology. Med (Kaunas). 2024;60(3):509. https:\/\/doi.org\/10.3390\/medicina60030509.","journal-title":"Med (Kaunas)"},{"issue":"4","key":"1280_CR4","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/nau.24900","volume":"41","author":"S Martin","year":"2022","unstructured":"Martin S, Zillioux J, Goldman HB. Is sacral neuromodulation effective in patients with parkinson\u2019s disease? A retrospective review. Neurourol Urodyn. 2022;41(4):955\u201361. https:\/\/doi.org\/10.1002\/nau.24900.","journal-title":"Neurourol Urodyn"},{"key":"1280_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.urology.2020.06.063","volume":"144","author":"DR Greenberg","year":"2020","unstructured":"Greenberg DR, Sohlberg EM, Zhang CA, Santini VE, Comiter CV, Enemchukwu EA. Sacral nerve stimulation in parkinson\u2019s disease patients with overactive bladder symptoms. Urology. 2020;144:99\u2013105. https:\/\/doi.org\/10.1016\/j.urology.2020.06.063.","journal-title":"Urology"},{"issue":"2","key":"1280_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00192-009-1023-6","volume":"21","author":"SP Marinkovic","year":"2010","unstructured":"Marinkovic SP, Gillen LM. Sacral neuromodulation for multiple sclerosis patients with urinary retention and clean intermittent catheterization. Int Urogynecol J. 2010;21(2):223\u20138. https:\/\/doi.org\/10.1007\/s00192-009-1023-6.","journal-title":"Int Urogynecol J"},{"issue":"1","key":"1280_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00345-011-0669-0","volume":"30","author":"D Minardi","year":"2012","unstructured":"Minardi D, Muzzonigro G. Sacral neuromodulation in patients with multiple sclerosis. World J Urol. 2012;30(1):123\u20138. https:\/\/doi.org\/10.1007\/s00345-011-0669-0.","journal-title":"World J Urol"},{"issue":"6","key":"1280_CR8","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/nau.24955","volume":"41","author":"A Chen","year":"2022","unstructured":"Chen A, Kapur A, Mossack S, Weissbart SJ, Kim JM. Initial experience using the axonics sacral neuromodulation system in patients with multiple sclerosis. Neurourol Urodyn. 2022;41(6):1373\u20139. https:\/\/doi.org\/10.1002\/nau.24955.","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"1280_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.7224\/1537-2073.2022-027","volume":"25","author":"E Thys","year":"2023","unstructured":"Thys E, Sasse K. Sacral neuromodulation therapy for urinary and fecal incontinence in patients with multiple sclerosis: report of 6 cases and literature review. Int J MS Care. 2023;25(4):163\u20137. https:\/\/doi.org\/10.7224\/1537-2073.2022-027.","journal-title":"Int J MS Care"},{"key":"1280_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.urology.2020.11.075","volume":"153","author":"G Chen","year":"2021","unstructured":"Chen G, Liao L, Deng H. The effect of sacral neuromodulation in ambulatory spina bifida patients with neurogenic bladder and bowel dysfunction. Urology. 2021;153:345\u201350. https:\/\/doi.org\/10.1016\/j.urology.2020.11.075.","journal-title":"Urology"},{"key":"1280_CR11","unstructured":"Leslie SW, Tadi P, Tayyeb M. Neurogenic bladder and neurogenic lower urinary tract dysfunction [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [updated 2023; cited 2025 Apr 13]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560617\/"},{"issue":"11","key":"1280_CR12","doi-asserted-by":"publisher","first-page":"EVIDoa2200071","DOI":"10.1056\/EVIDoa2200071","volume":"1","author":"MD Liechti","year":"2022","unstructured":"Liechti MD, van der Lely S, Kn\u00fcpfer SC, Abt D, Kiss B, Leitner L, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction. NEJM Evid. 2022;1(11):EVIDoa2200071. https:\/\/doi.org\/10.1056\/EVIDoa2200071.","journal-title":"NEJM Evid"},{"issue":"4","key":"1280_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.5213\/inj.2448144.122","volume":"28","author":"K Buford","year":"2024","unstructured":"Buford K, Eisner H, Vollstedt A, Friedman B, Gilleran J, Zwaans BMM, et al. Implantable neuromodulation for neurogenic lower urinary tract dysfunction: a single-institution retrospective study. Int Neurourol J. 2024;28(4):278\u201384. https:\/\/doi.org\/10.5213\/inj.2448144.122.","journal-title":"Int Neurourol J"},{"issue":"7","key":"1280_CR14","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/ner.13383","volume":"24","author":"I Masood","year":"2021","unstructured":"Masood I, Chen Q, Li J, Xu Z, Ying X, Wang Y, et al. Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction: a multicenter retrospective study from China. Neuromodulation. 2021;24(7):1278\u201383. https:\/\/doi.org\/10.1111\/ner.13383.","journal-title":"Neuromodulation"},{"key":"1280_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-16-7939-1_83-1","volume-title":"Handbook of neurourology","author":"L Liao","year":"2023","unstructured":"Liao L, Madersbacher H. Future direction for treatment of neurogenic lower urinary tract dysfunction. In: Liao L, Madersbacher H, editors. Handbook of neurourology. Singapore: Springer; 2023. pp. 1\u201310. https:\/\/doi.org\/10.1007\/978-981-16-7939-1_83-1."},{"issue":"1","key":"1280_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3978\/j.issn.2223-4683.2015.12.01","volume":"5","author":"MT Sanford","year":"2016","unstructured":"Sanford MT, Suskind AM. Neuromodulation in neurogenic bladder. Transl Androl Urol. 2016;5(1):117\u201326. https:\/\/doi.org\/10.3978\/j.issn.2223-4683.2015.12.01.","journal-title":"Transl Androl Urol"},{"issue":"4","key":"1280_CR17","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s12325-021-01650-9","volume":"38","author":"A Van Ophoven","year":"2021","unstructured":"Van Ophoven A, Engelberg S, Lilley H, Sievert KD. Systematic literature review and meta-analysis of sacral neuromodulation (SNM) in patients with neurogenic lower urinary tract dysfunction (nLUTD): over 20 years\u2019 experience and future directions. Adv Ther. 2021;38(4):1987\u20132006. https:\/\/doi.org\/10.1007\/s12325-021-01650-9.","journal-title":"Adv Ther"},{"issue":"Suppl 2","key":"1280_CR18","doi-asserted-by":"publisher","first-page":"S467","DOI":"10.1007\/s00192-010-1276-0","volume":"21","author":"PE Van Kerrebroeck","year":"2010","unstructured":"Van Kerrebroeck PE. Advances in the role of sacral nerve neuromodulation in lower urinary tract symptoms. Int Urogynecol J. 2010;21(Suppl 2):S467\u201374. https:\/\/doi.org\/10.1007\/s00192-010-1276-0.","journal-title":"Int Urogynecol J"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-025-01280-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-025-01280-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-025-01280-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:23:56Z","timestamp":1767939836000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-025-01280-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1280"],"URL":"https:\/\/doi.org\/10.1007\/s11934-025-01280-6","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"9 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Nissrine Nakib, MD, consultant with financial relationships with Axonics, Neuspera, and Inspire.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"52"}}